These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Insulin-infusion-pump treatment of diabetes: influence of improved metabolic control on plasma somatomedin levels. Tamborlane WV; Hintz RL; Bergman M; Genel M; Felig P; Sherwin RS N Engl J Med; 1981 Aug; 305(6):303-7. PubMed ID: 7017416 [TBL] [Abstract][Full Text] [Related]
26. Isolation of a somatomedin from plasma of rats bearing growth hormone secreting tumors. Chochinov RH; Mariz IK; Daughaday WH Endocrinology; 1977 Feb; 100(2):549-56. PubMed ID: 188631 [TBL] [Abstract][Full Text] [Related]
27. Serum somatomedin peptides measured by somatomedin A radioreceptor assay in chronic liver disease. Takano K; Hizuka N; Shizume K; Hayashi N; Motoike Y; Obata H J Clin Endocrinol Metab; 1977 Oct; 45(4):828-32. PubMed ID: 914986 [TBL] [Abstract][Full Text] [Related]
28. Production of insulin-like growth factor I and its binding protein in rat hepatocytes cultured from diabetic and insulin-treated diabetic rats. Scott CD; Baxter RC Endocrinology; 1986 Nov; 119(5):2346-52. PubMed ID: 2945714 [TBL] [Abstract][Full Text] [Related]
29. Raised plasma somatomedin activity and cartilage metabolic activity (35S sulphate uptake in vitro) in the fetus of the mildly diabetic pregnant rat. Hill DJ; Sheffrin RA; Milner RD Diabetologia; 1982 Sep; 23(3):270-4. PubMed ID: 6751907 [TBL] [Abstract][Full Text] [Related]
30. Changes in serum somatomedin A and its binding to kidney membranes in growing rats. Hizuka N; Takano K; Shizume K; Hasumi Y Acta Endocrinol (Copenh); 1981 Jul; 97(3):352-7. PubMed ID: 7257700 [TBL] [Abstract][Full Text] [Related]
32. Somatomedin inhibitors in serum and liver of growth hormone-deficient diabetic rats. Vassilopoulou-Sellin R; Oyedeji CO; Samaan NA Diabetes; 1983 Mar; 32(3):262-4. PubMed ID: 6825966 [TBL] [Abstract][Full Text] [Related]
33. Nutrition and somatomedin. XV. Growth plate, growth factor and biologically active somatomedins in rats with streptozotocin-induced diabetes. Goldstein S; Unterman TG; Phillips LS Ann Nutr Metab; 1987; 31(6):367-77. PubMed ID: 3426154 [TBL] [Abstract][Full Text] [Related]
34. Low serum somatomedin-C in insulin-dependent diabetes: evidence for a postreceptor mechanism. Maes M; Underwood LE; Ketelslegers JM Endocrinology; 1986 Jan; 118(1):377-82. PubMed ID: 3000746 [TBL] [Abstract][Full Text] [Related]
35. Somatostatin analogue administration prevents increase in kidney somatomedin C and initial renal growth in diabetic and uninephrectomized rats. Flyvbjerg A; Frystyk J; Thorlacius-Ussing O; Orskov H Diabetologia; 1989 Apr; 32(4):261-5. PubMed ID: 2759363 [TBL] [Abstract][Full Text] [Related]
36. Nutrition and somatomedin--XII. Fractionation of somatomedins and somatomedin inhibitors in normal and diabetic rats. Phillips LS; Bajaj VR; Fusco AC; Keery KM; Goldstein S Int J Biochem; 1985; 17(5):597-603. PubMed ID: 4029480 [TBL] [Abstract][Full Text] [Related]
37. Kidney tissue somatomedin C and initial renal growth in diabetic and uninephrectomized rats. Flyvbjerg A; Thorlacius-Ussing O; Naeraa R; Ingerslev J; Orskov H Diabetologia; 1988 May; 31(5):310-4. PubMed ID: 2456236 [TBL] [Abstract][Full Text] [Related]
38. Obesity and diabetes - a possible experimental model of maturity-onset-type diabetes. Inoue S; Iizuka T; Murao S Int J Obes; 1982; 6 Suppl 1():27-33. PubMed ID: 6214517 [TBL] [Abstract][Full Text] [Related]
39. Glucocorticoid effects on somatomedins and somatomedin inhibitors. Unterman TG; Phillips LS J Clin Endocrinol Metab; 1985 Oct; 61(4):618-26. PubMed ID: 4031007 [TBL] [Abstract][Full Text] [Related]
40. Nutrition and somatomedin. XVI: Somatomedins and somatomedin inhibitors in fasted and refed rats. Phillips LS; Goldstein S; Gavin JR Metabolism; 1988 Mar; 37(3):209-16. PubMed ID: 2449597 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]